Cargando…
Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
BACKGROUND: Glioblastoma (GBM) is the most common malignant brain tumor with median survival of 12-15 months. Owing to uncertainty in clinical outcome, additional prognostic marker(s) apart from existing markers are needed. Since overexpression of endothelin B receptor (ETBR) has been demonstrated i...
Autores principales: | Vasaikar, Suhas, Tsipras, Giorgos, Landázuri, Natalia, Costa, Helena, Wilhelmi, Vanessa, Scicluna, Patrick, Cui, Huanhuan L., Mohammad, Abdul-Aleem, Davoudi, Belghis, Shang, Mingmei, Ananthaseshan, Sharan, Strååt, Klas, Stragliotto, Giuseppe, Rahbar, Afsar, Wong, Kum Thong, Tegner, Jesper, Yaiw, Koon-Chu, Söderberg-Naucler, Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801893/ https://www.ncbi.nlm.nih.gov/pubmed/29409474 http://dx.doi.org/10.1186/s12885-018-4012-7 |
Ejemplares similares
-
Human cytomegalovirus may promote tumour progression by upregulating arginase-2
por: Costa, Helena, et al.
Publicado: (2016) -
Human Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies?
por: Yaiw, Koon-Chu, et al.
Publicado: (2015) -
The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection
por: Landázuri, Natalia, et al.
Publicado: (2021) -
Detection of Circulating hcmv-miR-UL112-3p in Patients with Glioblastoma, Rheumatoid Arthritis, Diabetes Mellitus and Healthy Controls
por: Mohammad, Abdul-Aleem, et al.
Publicado: (2014) -
Human Cytomegalovirus Reduces Endothelin-1 Expression in Both Endothelial and Vascular Smooth Muscle Cells
por: Yaiw, Koon-Chu, et al.
Publicado: (2021)